In 2025, Kobayashi Pharmaceutical conducted an environmental assessment and disclosed corporate waste management data in accordance with recognized sustainability reporting standards.The company provided a breakdown of its waste by treatment method (recovery vs disposal), enabling greater transparency into its waste handling and environmental practices.
| Metric (tonnes) | 2025 | 2024 | 2023 | 2022-2019 |
|---|---|---|---|---|
Total Waste Generated | 2,076a | 2,292a | 2,497a | |
Total Waste Recovered | 2,072a | 2,283a | 2,494a | |
Total Hazardous Waste Generated | N/A | N/A | N/A | |
Non-Hazardous Waste Disposed | N/A | N/A | N/A |
You are welcome to quote or reference individual data points from this page, provided you include the following attribution with a visible, clickable link to this page: "Source: Tracenable, the global reference for ESG data"
Bulk collection, scraping, resale, or redistribution of data across multiple company profiles is not permitted without our prior written permission. For more information, see our General Terms and Conditions.
Every figure on this dashboard has a transparent audit trail. With Tracenable, each data point is traceable back to its original source, viewable directly inside our platform.
In 2025, Kobayashi Pharmaceutical generated a total of 2,076metric tonnes of waste.a
Of this amount, 99.81% of Kobayashi Pharmaceutical's total waste generated was recovered through methods such as recycling, reuse, or composting, while 0.19% was disposed of through landfilling, incineration, or combustion.a
In 2025, Kobayashi Pharmaceutical reported a total waste generation of 2,076 metric tonnes, of which 99.81% was recovered through recycling, reuse, or composting.This high recovery rate suggests that Kobayashi Pharmaceutical has implemented strong circular economy practices and actively prioritizes sustainable waste management.a
Since 2021, Kobayashi Pharmaceutical's total waste generation decreased by 12.44%, including a further 9.42% drop in 2025, highlighting a consistent and deliberate reduction in waste production over time.a
Over the same period, Kobayashi Pharmaceutical's waste recovery rate remained stable both in the long term and in 2025, suggesting limited progress, or consistent recovery performance, without major shifts in strategy.a
Overall, Kobayashi Pharmaceutical’s waste generation and recovery data show a mixed and inconsistent trend. A deeper analysis of the company's activities, industry benchmarks, and operational changes is needed to assess its sustainability performance more precisely.